Randomization in clinical research refers to the process of assigning participants to different treatment groups by chance. This method ensures that each participant has an equal probability of being allocated to any group, reducing selection bias and creating comparable study arms.
The goal of randomization is to distribute both known and unknown factors that may influence the study outcomes evenly across groups. By doing so, it helps to isolate the effects of the intervention being studied and increases the validity of the research findings.
Randomization is crucial in clinical research as it minimizes bias and ensures the scientific integrity of study results. By eliminating systematic differences between treatment groups, it allows researchers to attribute observed effects to the intervention rather than confounding variables.
Furthermore, randomization enhances the generalizability of study findings to broader populations. It enables statistical inference and supports the validity of hypothesis testing, making it a cornerstone of evidence-based medicine and regulatory approval processes for new treatments.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2025 Axcellant